Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
December 08 2022 - 8:41PM
Business Wire
Transaction Highlights
- Walgreens Boots Alliance announces the sale of shares of
AmerisourceBergen Corporation for proceeds of approximately $1.0
billion
- Approximately $0.8 billion sold pursuant to Rule 144 along with
a concurrent share repurchase by AmerisourceBergen of approximately
$0.2 billion
- Proceeds to Walgreens Boots Alliance will be used primarily for
debt paydown and the funding of the company’s strategic priorities,
including the definitive agreement for VillageMD to acquire Summit
Health-CityMD
- No change to ongoing collaboration and long-term strategic
partnership
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced
that it has sold shares of AmerisourceBergen Corporation (NYSE:
ABC) common stock pursuant to Rule 144 for proceeds of
approximately $0.8 billion and, subject to the completion of the
Rule 144 sale, a concurrent share repurchase by AmerisourceBergen
for proceeds of approximately $0.2 billion.
Walgreens Boots Alliance’s ownership of AmerisourceBergen’s
common stock has decreased from approximately 20 percent to
approximately 17 percent.
Proceeds to Walgreens Boots Alliance will be used primarily for
debt paydown and the funding of the company’s strategic priorities,
including the definitive agreement for VillageMD to acquire Summit
Health-CityMD.
The sale has no impact to the long-term partnership between the
two companies. Walgreens Boots Alliance remains fully committed to
the strategic, mutually beneficial relationship with
AmerisourceBergen, which has been a strong and trusted partner
since 2013. Chief Operating Officer, International of Walgreens
Boots Alliance, Ornella Barra, will continue to serve on
AmerisourceBergen’s Board of Directors.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated
healthcare, pharmacy and retail leader serving millions of
customers and patients every day, with a 170-year heritage of
caring for communities.
A trusted, global innovator in retail pharmacy with
approximately 13,000 locations across the U.S., Europe and Latin
America, WBA plays a critical role in the healthcare ecosystem. The
company is reimagining local healthcare and well-being for all as
part of its purpose – to create more joyful lives through better
health. Through dispensing medicines, improving access to a wide
range of health services, providing high quality health and beauty
products and offering anytime, anywhere convenience across its
digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 325,000 people and has a presence in nine
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and
Ahumada in Chile. Additionally, WBA has a portfolio of
healthcare-focused investments located in several countries,
including China and the U.S.
The company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to operating sustainably: the company is an index component of the
Dow Jones Sustainability Indices (DJSI) and was named to the 100
Best Corporate Citizens 2022.
WBA-GEN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221208006102/en/
WBA Media Relations USA / Jim Cohn, +1 224 813 9057
International, +44 (0)20 7980 8585
WBA Investor Relations Tiffany Kanaga, +1 847 315
2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Apr 2023 to Apr 2024